199 related articles for article (PubMed ID: 35636177)
1. Dendrobine inhibits dopaminergic neuron apoptosis via MANF-mediated ER stress suppression in MPTP/MPP
Li QM; Li X; Su SQ; Wang YT; Xu T; Zha XQ; Pan LH; Shang ZZ; Zhang FY; Luo JP
Phytomedicine; 2022 Jul; 102():154193. PubMed ID: 35636177
[TBL] [Abstract][Full Text] [Related]
2. Mesencephalic astrocyte-derived neurotrophic factor (MANF) protects against Aβ toxicity via attenuating Aβ-induced endoplasmic reticulum stress.
Xu S; Di Z; He Y; Wang R; Ma Y; Sun R; Li J; Wang T; Shen Y; Fang S; Feng L; Shen Y
J Neuroinflammation; 2019 Feb; 16(1):35. PubMed ID: 30760285
[TBL] [Abstract][Full Text] [Related]
3. Mesencephalic astrocyte-derived neurotrophic factor (MANF) prevents the neuroinflammation induced dopaminergic neurodegeneration.
Zhang JX; Zhou KG; Yin YX; Jin LJ; Tong WF; Guo J; Yu LH; Ye XC; Jiang M
Exp Gerontol; 2023 Jan; 171():112037. PubMed ID: 36436758
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson's disease.
Voutilainen MH; Arumäe U; Airavaara M; Saarma M
FEBS Lett; 2015 Dec; 589(24 Pt A):3739-48. PubMed ID: 26450777
[TBL] [Abstract][Full Text] [Related]
5. MANF protects dopamine neurons and locomotion defects from a human α-synuclein induced Parkinson's disease model in C. elegans by regulating ER stress and autophagy pathways.
Zhang Z; Shen Y; Luo H; Zhang F; Peng D; Jing L; Wu Y; Xia X; Song Y; Li W; Jin L
Exp Neurol; 2018 Oct; 308():59-71. PubMed ID: 29959908
[TBL] [Abstract][Full Text] [Related]
6. Mesencephalic astrocyte-derived neurotrophic factor: A treatment option for parkinson's disease.
Yang C; Gao Y
Front Biosci (Landmark Ed); 2020 Jun; 25(9):1718-1731. PubMed ID: 32472754
[TBL] [Abstract][Full Text] [Related]
7. PPARβ/δ Agonist Provides Neuroprotection by Suppression of IRE1α-Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson's Disease.
Tong Q; Wu L; Gao Q; Ou Z; Zhu D; Zhang Y
Mol Neurobiol; 2016 Aug; 53(6):3822-3831. PubMed ID: 26160761
[TBL] [Abstract][Full Text] [Related]
8. Ganoderic acid A mitigates dopaminergic neuron ferroptosis via inhibiting NCOA4-mediated ferritinophagy in Parkinson's disease mice.
Li QM; Wu SZ; Zha XQ; Zang DD; Zhang FY; Luo JP
J Ethnopharmacol; 2024 Oct; 332():118363. PubMed ID: 38763373
[TBL] [Abstract][Full Text] [Related]
9. MANF regulates neuronal survival and UPR through its ER-located receptor IRE1α.
Kovaleva V; Yu LY; Ivanova L; Shpironok O; Nam J; Eesmaa A; Kumpula EP; Sakson S; Toots U; Ustav M; Huiskonen JT; Voutilainen MH; Lindholm P; Karelson M; Saarma M
Cell Rep; 2023 Feb; 42(2):112066. PubMed ID: 36739529
[TBL] [Abstract][Full Text] [Related]
10. Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism.
Lindholm P; Saarma M
Mol Psychiatry; 2022 Mar; 27(3):1310-1321. PubMed ID: 34907395
[TBL] [Abstract][Full Text] [Related]
11. Mesencephalic astrocyte-derived neurotrophic factor alleviated 6-OHDA-induced cell damage via ROS-AMPK/mTOR mediated autophagic inhibition.
Zhang J; Cai Q; Jiang M; Liu Y; Gu H; Guo J; Sun H; Fang J; Jin L
Exp Gerontol; 2017 Mar; 89():45-56. PubMed ID: 28099881
[TBL] [Abstract][Full Text] [Related]
12. Buddlejasaponin IVb ameliorates ferroptosis of dopaminergic neuron by suppressing IRP2-mediated iron overload in Parkinson's disease.
Li QM; Xu T; Zha XQ; Feng XW; Zhang FY; Luo JP
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117196. PubMed ID: 37717841
[TBL] [Abstract][Full Text] [Related]
13. MANF improves the MPP
Liu Y; Zhang J; Jiang M; Cai Q; Fang J; Jin L
Am J Transl Res; 2018; 10(5):1284-1294. PubMed ID: 29887945
[TBL] [Abstract][Full Text] [Related]
14. CDNF and MANF regulate ER stress in a tissue-specific manner.
Pakarinen E; Lindholm P; Saarma M; Lindahl M
Cell Mol Life Sci; 2022 Feb; 79(2):124. PubMed ID: 35129674
[TBL] [Abstract][Full Text] [Related]
15. Long-term protective effects of AAV9-mesencephalic astrocyte-derived neurotrophic factor gene transfer in parkinsonian rats.
Hao F; Yang C; Chen SS; Wang YY; Zhou W; Hao Q; Lu T; Hoffer B; Zhao LR; Duan WM; Xu QY
Exp Neurol; 2017 May; 291():120-133. PubMed ID: 28131727
[TBL] [Abstract][Full Text] [Related]
16. Current disease modifying approaches to treat Parkinson's disease.
Lindholm D; Mäkelä J; Di Liberto V; Mudò G; Belluardo N; Eriksson O; Saarma M
Cell Mol Life Sci; 2016 Apr; 73(7):1365-79. PubMed ID: 26616211
[TBL] [Abstract][Full Text] [Related]
17. Novel CDNF/MANF family of neurotrophic factors.
Lindholm P; Saarma M
Dev Neurobiol; 2010 Apr; 70(5):360-71. PubMed ID: 20186704
[TBL] [Abstract][Full Text] [Related]
18. The cytoprotective protein MANF promotes neuronal survival independently from its role as a GRP78 cofactor.
Eesmaa A; Yu LY; Göös H; Nõges K; Kovaleva V; Hellman M; Zimmermann R; Jung M; Permi P; Varjosalo M; Lindholm P; Saarma M
J Biol Chem; 2021; 296():100295. PubMed ID: 33460650
[TBL] [Abstract][Full Text] [Related]
19. Modulation of endoplasmic reticulum stress in Parkinson's disease.
Tsujii S; Ishisaka M; Hara H
Eur J Pharmacol; 2015 Oct; 765():154-6. PubMed ID: 26297973
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
